BiotechTube

IgPro10

ApprovedRecruiting
1 views this week 0 watching⚡ Active
Interest: 50/100
50
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Conditions

Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Trial Timeline

Feb 28, 2019 → Dec 20, 2029

NCT ID
NCT03684018

About IgPro10

IgPro10 is a approved stage product being developed by CSL for Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). The current trial status is recruiting. This product is registered under clinical trial identifier NCT03684018. Target conditions include Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).

What happened to similar drugs?

2 of 18 similar drugs in Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) were approved

Approved (2) Terminated (0) Active (16)
🔄candsartan cilexetilAstraZenecaPhase 3
🔄basiliximab, MMF(mycophenolate mofetil), cyclosporine, prednisone (or equivalent) + MMF, cyclosporine, steroidsNovartisPhase 3
🔄VAL489 + VAL489 matching placeboNovartisPhase 3
🔄Entecavir + Lamivudine + Pegylated Interferon Alfa-2ARochePhase 3
🔄EtanerceptAmgenPhase 3
🔄DenosumabAmgenPhase 3
🔄RomiplostimAmgenPhase 3

Hype Score Breakdown

Clinical
20
Activity
15
Company
15
Novelty
0
Community
0

Clinical Trials (2)

NCT IDPhaseStatus
NCT03684018ApprovedRecruiting
NCT01390649ApprovedCompleted

Competing Products

20 competing products in Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

See all competitors
ProductCompanyStageHype Score
RamucirumabEli LillyPhase 1
29
erlotinib + etoposideAstellas PharmaPhase 2
27
Mitoxantrone Hydrochloride Liposome + Irinotecan + VincristineSun PharmaceuticalPhase 1
33
Perampanel Oral Suspension + Perampanel TabletEisaiPhase 2
42
Eribulin MesylateEisaiPhase 1
29
Decitabine + DecitabineEisaiPhase 2
27
Dasotraline 1 mg, 2 mg, 4 mg, 8 mg, 12 mg, 16 mg, 20 mg, 24 mg, 28 mg, 32 mg once dailySumitomo PharmaPhase 1
29
Remimazolam Tosilate for injection + Propofol InjectionJiangsu Hengrui MedicinePhase 2/3
45
Ceftaroline fosamil + Vancomycin +/- Aztreonam or Cefazolin +/- Aztreonam + Cephalexin or Clindamycin or LinezolidAstraZenecaPhase 2/3
38
candsartan cilexetilAstraZenecaPhase 3
40
Durvalumab / Tremelimumab Combination TherapyAstraZenecaPhase 1/2
36
Rotavirus VaccineMerckPre-clinical
18
basiliximab, MMF(mycophenolate mofetil), cyclosporine, prednisone (or equivalent) + MMF, cyclosporine, steroidsNovartisPhase 3
40
VAL489 + VAL489 matching placeboNovartisPhase 3
40
LCZ696 + Enalapril + Placebo of LCZ696 + Placebo of Enalapril + LCZ696NovartisPhase 2/3
38
EverolimusNovartisPhase 2
35
Corticosteroids + Cyclosporine + mycophenolate mofetilRochePhase 2
27
Entecavir + Lamivudine + Pegylated Interferon Alfa-2ARochePhase 3
40
Blinatumomab for InjectionAmgenPhase 1
25
EtanerceptAmgenPhase 3
40